市場調査レポート

商品コード

1722463

バイオテクノロジー市場レポート：製品タイプ、技術、用途、地域別、2025年～2033年

Biotechnology Market Report by Product Type, Technology, Application, and Region 2025-2033

出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 438,093円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 584,173円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 730,253円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のバイオテクノロジー市場規模は2024年に7,615億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに1兆3,159億米ドルに達し、2025年から2033年にかけて6.27%の成長率（CAGR）を示すと予測しています。個別化医療の研究開発（R&D）の増加、遺伝子工学の数多くの進歩、持続可能な農業への需要の高まりなどが、市場を推進する主な要因となっています。

バイオテクノロジーは、革新的な製品や技術を開発するために生物、細胞、生物システムを利用する学際的な分野です。分子・細胞レベルの生物学的プロセスや生物を活用し、ヘルスケア、農業、環境管理など、業界を横断するさまざまな課題に取り組みます。バイオテクノロジーには、遺伝子工学、バイオ医薬品、バイオインフォマティクス、合成生物学などの分野が含まれ、これらはすべて、新たなソリューションの創造、既存のプロセスの改善、生命システムの理解の向上を目的としています。この分野は、現代医療、持続可能な農業、多様な用途のための新素材の開発を形成する上で重要な役割を果たしています。

遺伝子研究と分子生物学の理解の急速な進歩により、遺伝子編集、個別化医療、新規治療などの分野で技術革新が進んでいることが、予測期間中の市場成長を刺激すると思われます。さらに、慢性疾患の有病率の増加と標的治療の必要性が、バイオ医薬品と精密医療に対する需要を増大させており、市場成長にプラスの影響を与えています。さらに、世界人口の増加と限られた耕地面積に起因する持続可能な農業ソリューションに対する需要の高まりが、作物改良と生物農薬におけるバイオテクノロジー技術の採用を加速させています。これとは別に、バイオインフォマティクスとして知られる情報技術とバイオテクノロジーとの融合が、研究開発のためのデータ駆動型洞察を強化し、市場の成長を促進しています。さらに、環境の持続可能性への注目の高まりによるバイオレメディエーション手法やバイオ燃料の市場開拓が、市場の成長に寄与しています。

バイオテクノロジー市場動向と促進要因：

遺伝子工学の急速な進歩

画期的なCRISPR-Cas9技術に代表される遺伝子工学の著しい進歩は、バイオテクノロジー市場の主要な促進要因です。この技術は、科学者が生物内の遺伝子を正確に改変することを可能にし、医療、農業、工業プロセスへの応用に前例のない可能性を提示しています。ヘルスケアでは、遺伝子工学は遺伝性疾患やがんに対する革新的な遺伝子治療の開発を促進し、個別化治療の有望な道を提供します。さらに、インスリンや酵素のような貴重な化合物の生産のために微生物を工学的に改良する能力は、製薬および工業製造に変革をもたらしました。

個別化医療と治療薬に対する需要の増加

個人の遺伝的体質に合わせた個別化医療の概念は、バイオテクノロジー市場で支持を集めています。ゲノム配列解析技術の進歩により、個人の遺伝コードを解析し、疾患に関連する遺伝子変異を特定することが可能になりました。これにより、患者固有の遺伝的特徴に対応した標的治療薬が開発され、治療効果の向上や副作用の軽減が期待されています。バイオテクノロジーは、モノクローナル抗体や遺伝子治療などのバイオ医薬品の製造を可能にし、個別化医療の原則に合致しています。さらに、遺伝子マーカーに基づく診断は、病気の早期発見と予後予測を可能にし、ヘルスケアをより正確で個別化されたアプローチへと再構築します。

持続可能な農業ソリューションへのニーズの高まり

世界の食糧需要の増大は、環境問題や持続可能な農業慣行の必要性と相まって、農業におけるバイオテクノロジー・ソリューションの採用を後押ししています。収穫量、害虫抵抗性、栄養価を高めるために遺伝子組み換え作物（GMO）は、バイオテクノロジーが農業に与える影響の一例です。自然界に存在する生物に由来する生物農薬は、環境への影響が少ないことから、従来の化学農薬よりも好まれるようになってきています。バイオテクノロジーは、植物の形質を最適化し、気候変動に対する作物の回復力を向上させ、栄養効率を高めるツールを提供し、食糧安全保障と資源の持続可能性に貢献しています。このドライバーは、エコロジカルフットプリントを最小限に抑えながら、農業分野の差し迫った課題に取り組むというバイオテクノロジーの重要な役割を反映しています。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場内訳：国別

第10章 SWOT分析

概要
強み
弱み
機会
脅威

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第13章価格分析

第14章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Amgen Inc.
- Biocon Limited
- Biogen Inc.
- F. Hoffmann-La Roche AG
- Genmab A/S
- Lonza Group AG
- Novartis AG
- Novo Nordisk A/S
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Seagen Inc.
- Syngenta AG
- Vertex Pharmaceuticals Incorporated

図表

List of Figures

Figure 1: Global: Biotechnology Market: Major Drivers and Challenges
Figure 2: Global: Biotechnology Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Biotechnology Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Biotechnology Market: Breakup by Product Type (in %), 2024
Figure 5: Global: Biotechnology Market: Breakup by Technology (in %), 2024
Figure 6: Global: Biotechnology Market: Breakup by Application (in %), 2024
Figure 7: Global: Biotechnology Market: Breakup by Region (in %), 2024
Figure 8: Global: Biotechnology (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Biotechnology (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Biotechnology (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Biotechnology (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Biotechnology (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Biotechnology (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Biotechnology (Nanobiotechnology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Biotechnology (Nanobiotechnology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Biotechnology (Tissue Engineering and Regeneration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Biotechnology (Tissue Engineering and Regeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Biotechnology (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Biotechnology (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Biotechnology (Cell-Based Assays) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Biotechnology (Cell-Based Assays) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Biotechnology (Fermentation) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Biotechnology (Fermentation) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Biotechnology (PCR Technology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Biotechnology (PCR Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Biotechnology (Chromatography) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Biotechnology (Chromatography) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Biotechnology (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Biotechnology (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Biotechnology (Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Biotechnology (Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Biotechnology (Food and Agriculture) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Biotechnology (Food and Agriculture) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Biotechnology (Natural Resources and Environment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Biotechnology (Natural Resources and Environment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Biotechnology (Industrial Processing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Biotechnology (Industrial Processing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Biotechnology (Bioinformatics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Biotechnology (Bioinformatics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Global: Biotechnology (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Global: Biotechnology (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: North America: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: North America: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: United States: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: United States: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Canada: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Canada: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Asia-Pacific: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Asia-Pacific: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: China: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: China: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Japan: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Japan: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: India: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: India: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: South Korea: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: South Korea: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Australia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Australia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Indonesia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Indonesia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Europe: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Europe: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Germany: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Germany: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: France: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: France: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: United Kingdom: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: United Kingdom: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Italy: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Italy: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Spain: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Spain: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Russia: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Russia: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Latin America: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Latin America: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Brazil: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Brazil: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Mexico: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Mexico: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Others: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Others: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 88: Middle East and Africa: Biotechnology Market: Sales Value (in Million USD), 2019 & 2024
Figure 89: Middle East and Africa: Biotechnology Market: Breakup by Country (in %), 2024
Figure 90: Middle East and Africa: Biotechnology Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Global: Biotechnology Industry: SWOT Analysis
Figure 92: Global: Biotechnology Industry: Value Chain Analysis
Figure 93: Global: Biotechnology Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Biotechnology Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Biotechnology Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 3: Global: Biotechnology Market Forecast: Breakup by Technology (in Million USD), 2025-2033
Table 4: Global: Biotechnology Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Biotechnology Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Biotechnology Market: Competitive Structure
Table 7: Global: Biotechnology Market: Key Players

Product Code: SR112025A5785

The global biotechnology market size reached USD 761.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 1,315.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.27% during 2025-2033. The increasing research and development (R&D) in personalized medicine, numerous advancements in genetic engineering, and escalating demand for sustainable agriculture are some of the major factors propelling the market.

Biotechnology is a multidisciplinary field that encompasses the use of living organisms, cells, and biological systems to develop innovative products and technologies. It involves harnessing biological processes and organisms at the molecular and cellular level to address various challenges across industries, such as healthcare, agriculture, and environmental management. Biotechnology includes areas like genetic engineering, biopharmaceuticals, bioinformatics, and synthetic biology, all aimed at creating new solutions, improving existing processes, and advancing our understanding of living systems. This field plays a crucial role in shaping modern medicine, sustainable agriculture, and the development of novel materials for diverse applications.

The rising innovation in areas, including gene editing, personalized medicine, and novel therapies, due to rapid advancements in genetic research and the understanding of molecular biology, will stimulate the market growth during the forecast period. Moreover, the increasing prevalence of chronic diseases and the need for targeted treatments have augmented the demand for biopharmaceuticals and precision medicine, thus positively influencing the market growth. Additionally, the heightening demand for sustainable agricultural solutions owing to the expanding global population and limited arable land has accelerated the adoption of biotechnological techniques in crop improvement and biopesticides. Apart from this, the convergence of biotechnology with information technology, known as bioinformatics, that enhances data-driven insights for research and development is propelling the market growth. Furthermore, the development of bioremediation methods and biofuels on account of the escalating focus on environmental sustainability is contributing to market growth.

Biotechnology Market Trends/Drivers:

Rapid advancements in genetic engineering

The remarkable progress in genetic engineering, prominently exemplified by the revolutionary CRISPR-Cas9 technology, represents a primary driver in the biotechnology market. This technique allows scientists to precisely modify genes within organisms, presenting unprecedented potential for applications in medicine, agriculture, and industrial processes. In healthcare, genetic engineering facilitates the development of innovative gene therapies for genetic disorders and cancers, offering promising avenues for personalized treatments. Moreover, the ability to engineer microbes for the production of valuable compounds like insulin and enzymes has transformed pharmaceutical and industrial manufacturing.

Increasing demand for personalized medicine and therapeutics

The concept of personalized medicine, tailored to an individual's genetic makeup, is gaining traction in the biotechnology market. Advancements in genomic sequencing technologies have made it possible to analyze an individual's genetic code and identify genetic variations linked to diseases. This has led to the development of targeted therapies that address the unique genetic characteristics of patients, enhancing treatment efficacy and reducing adverse effects. Biotechnology enables the production of biopharmaceuticals such as monoclonal antibodies and gene therapies, aligning with the principles of personalized medicine. Additionally, diagnostics based on genetic markers allow for early disease detection and prognosis, reshaping healthcare practices toward more precise and individualized approaches.

Rising need for sustainable agriculture solutions

The increasing global demand for food, coupled with environmental concerns and the need for sustainable agricultural practices, fuels the adoption of biotechnological solutions in farming. Genetically modified crops (GMOs) engineered for enhanced yield, pest resistance, and nutritional content are examples of biotechnology's influence on agriculture. Biopesticides derived from naturally occurring organisms are gaining preference over traditional chemical pesticides owing to their reduced environmental impact. Biotechnology offers tools to optimize plant traits, improve crop resilience to climate change, and increase nutrient efficiency, contributing to food security and resource sustainability. This driver reflects the critical role of biotechnology in addressing pressing challenges within the agriculture sector while minimizing ecological footprints.

Biotechnology Industry Segmentation:

Breakup by Product Type:

Instruments
Reagents
Software and Services

Instruments form the foundation of advanced research and diagnostics, enabling precise analysis and experimentation. Reagents are essential components that fuel experimental processes, facilitating accurate results and breakthroughs. Software plays a pivotal role, providing data analysis, visualization, and integration solutions, enhancing efficiency and accuracy in biotechnological endeavors. Services encompass consulting, training, and technical support, nurturing collaboration and aiding in the effective utilization of tools.

Furthermore, these components synergistically push the boundaries of biotechnology, fostering innovation and driving advancements that impact diverse sectors such as healthcare, agriculture, and environmental sciences. As the industry evolves, the strategic interplay of instruments, reagents, software, and services continues to shape the trajectory of biotechnology, fueling growth, discovery, and progress.

Breakup by Technology:

Nanobiotechnology
Tissue Engineering and Regeneration
DNA Sequencing
Cell-Based Assays
Fermentation
PCR Technology
Chromatography
Others

Nanobiotechnology integrates nanoscale materials with biological systems, revolutionizing drug delivery, diagnostics, and therapies. Tissue engineering and regeneration pioneers novel approaches for creating functional tissues, addressing organ shortages and medical needs. DNA sequencing enables comprehensive genomic analysis, guiding personalized medicine and disease understanding. Cell-based assays provide insights into cellular behavior, supporting drug development and toxicity testing. Fermentation is a cornerstone for bioprocessing, producing biofuels, pharmaceuticals, and enzymes. PCR Technology amplifies DNA, underpinning diagnostics and genetic research.

Chromatography separates biomolecules with precision, crucial in drug purification and analytical processes. These intertwined advancements drive the market's progress, fostering innovation and solutions across healthcare, agriculture, and environmental sectors.

Breakup by Application:

Healthcare
Food and Agriculture
Natural Resources and Environment
Industrial Processing
Bioinformatics
Others

Healthcare dominates the market

Healthcare serves as a pivotal driving force behind the biotechnology market, catalyzing innovations that transform patient care and medical practices. Biotechnology solutions play a vital role in diagnostics, treatment development, and personalized medicine. From advanced DNA sequencing enabling precise disease identification to biopharmaceuticals revolutionizing treatment modalities, the synergy between healthcare and biotechnology yields breakthrough therapies, improved patient outcomes, and enhanced disease management.

As healthcare and biotechnology intertwine, novel discoveries in areas such as gene editing, synthetic biology, and biomarker development further propelling the market growth. The biotechnology sector's continual evolution addresses current medical challenges and paves the way for future advancements, shaping the landscape of healthcare delivery and underscoring its significance as a critical driver of progress within the biotechnology domain.

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region boasts a robust ecosystem of research, innovation, and industry collaboration. The region's strong investment in research and development (R&D), coupled with its well-established regulatory frameworks, fosters an environment conducive to biotechnological breakthroughs. Various leading universities, research institutions, and biotech companies converge to push the boundaries of scientific discovery and technological advancements.

Furthermore, the rising emphasis of the North America region on entrepreneurship and venture capital further accelerates the commercialization of novel biotech solutions. With a history of pioneering achievements in areas such as genomics, pharmaceuticals, and medical devices, North America's influential role continues to shape the global biotechnology landscape, catalyzing growth, fostering innovation, and driving positive societal and economic impacts.

Competitive Landscape:

Key players in the biotechnology market have introduced groundbreaking innovations. Leading biopharmaceutical companies are developing mRNA-based vaccines that demonstrated remarkable efficacy in pandemic response. Additionally, advancements in CRISPR-based gene editing techniques have enabled precise and efficient modifications in various organisms, promising transformative applications in genetic therapies and modified crops. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in drug discovery and development processes is accelerating the identification of potential drug candidates. These innovations reflect the industry's commitment to addressing global challenges, ranging from disease outbreaks to food security, through cutting-edge biotechnological solutions with the potential to reshape medical treatments, agriculture practices, and industrial processes. We also expect the market to witness new entrants, consolidation of portfolios, and an increase in strategic partnerships and collaborations among vendors to drive healthy competition within the domain during the forecast period.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Amgen Inc.
Biocon Limited
Biogen Inc.
F. Hoffmann-La Roche AG
Genmab A/S
Lonza Group AG
Novartis AG
Novo Nordisk A/S
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Seagen Inc.
Syngenta AG
Vertex Pharmaceuticals Incorporated

Recent Developments:

In May 2022, F. Hoffmann-La Roche Ltd, a leading healthcare enterprise headquartered in Switzerland, introduced the innovative breast cancer antibody cocktail drug, PHESGO, to the Indian market. This breakthrough offering comes with a compelling advantage, as it is not only priced at a remarkable 20% lower than existing therapies but also offers a more streamlined and convenient administration process. It specifically targets HER-2 positive breast cancer, a challenging and prevalent subtype, while holding the distinction of being sanctioned for both early and advanced stages, including metastatic cases.

In January 2021, Novartis AG, a renowned pharmaceutical leader, entered into a strategic collaboration with Alnylam, a pioneering biotechnology company specializing in RNA interference (RNAi) technology. This innovative partnership aims to harness Alnylam's cutting-edge small interfering RNA (siRNA) technology to pave the way for a revolutionary targeted therapy. The focus of this collaboration centers on restoring optimal liver function, a critical aspect in numerous medical conditions.

In Jan 2023, Pfizer Inc., a global leader in biopharmaceuticals, collaborated with Gero, an avant-garde biotechnology company renowned for its advanced technology platform. This strategic research collaboration marks a convergence of expertise and technology, aiming to unlock new insights into the complex realm of fibrotic diseases. By harnessing Pfizer's extensive domain knowledge and Gero's state-of-the-art machine-learning capabilities, the partnership endeavors to chart unexplored territories in the understanding of genes and pathways linked to fibrosis - a group of disorders characterized by tissue scarring and dysfunction.

Key Questions Answered in This Report

1.How big is the biotechnology market?
2.What is the expected growth rate of the global biotechnology market during 2025-2033?
3.What are the key factors driving the global biotechnology market?
4.What has been the impact of COVID-19 on the global biotechnology market?
5.What is the breakup of the global biotechnology market based on the application?
6.What are the key regions in the global biotechnology market?
7.Who are the key players/companies in the global biotechnology market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Biotechnology Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Instruments
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Reagents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Software and Services
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Technology

7.1 Nanobiotechnology
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Tissue Engineering and Regeneration
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 DNA Sequencing
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Cell-Based Assays
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Fermentation
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 PCR Technology
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
7.7 Chromatography
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
7.8 Others
- 7.8.1 Market Trends
- 7.8.2 Market Forecast

8 Market Breakup by Application

8.1 Healthcare
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Food and Agriculture
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Natural Resources and Environment
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Industrial Processing
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Bioinformatics
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Amgen Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
- 14.3.2 Biocon Limited
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Biogen Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 F. Hoffmann-La Roche AG
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
- 14.3.5 Genmab A/S
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
  - 14.3.5.4 SWOT Analysis
- 14.3.6 Lonza Group AG
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Novartis AG
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
  - 14.3.7.4 SWOT Analysis
- 14.3.8 Novo Nordisk A/S
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Pfizer Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 Regeneron Pharmaceuticals Inc.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials
  - 14.3.10.4 SWOT Analysis
- 14.3.11 Seagen Inc.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Syngenta AG
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 SWOT Analysis
- 14.3.13 Vertex Pharmaceuticals Incorporated
  - 14.3.13.1 Company Overview
  - 14.3.13.2 Product Portfolio
  - 14.3.13.3 Financials
  - 14.3.13.4 SWOT Analysis

バイオテクノロジー市場レポート：製品タイプ、技術、用途、地域別、2025年～2033年

Biotechnology Market Report by Product Type, Technology, Application, and Region 2025-2033

バイオテクノロジー市場動向と促進要因：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のバイオテクノロジー市場

第6章 市場内訳：製品タイプ別

第7章 市場内訳：技術別

第8章 市場内訳：用途別

第9章 市場内訳：地域別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格分析

第14章 競合情勢